{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:02:00Z","timestamp":1789142520318,"version":"build-2803163510"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115859","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T18:42:19Z","timestamp":1424457739000},"page":"e0115859","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Screening the Medicines for Malaria Venture \"Malaria Box\" against the Plasmodium falciparum Aminopeptidases, M1, M17 and M18"],"prefix":"10.1371","volume":"10","author":[{"given":"Alessandro","family":"Paiardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Bamert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komagal","family":"Kannan-Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyssa","family":"Drinkwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh N.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Scammells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation (2013) World Malaria Report 2013. WHO Library Cataloguing-in-Publication Data. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/malaria\" xlink:type=\"simple\">http:\/\/www.who.int\/malaria<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant <italic>Plasmodium falciparum<\/italic> malaria","volume":"505","author":"F Ariey","year":"2014","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: a drug discovery catalyst for neglected diseases","volume":"8","author":"T Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.sbi.2013.07.015","article-title":"Working in concert: the metalloaminopeptidases from <italic>Plasmodium falciparum<\/italic>","volume":"23","author":"S McGowan","year":"2013","journal-title":"Curr Opin Struct Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1073\/pnas.0911813107","article-title":"Structure of the <italic>Plasmodium falciparum<\/italic> M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases","volume":"107","author":"S McGowan","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1073\/pnas.0807398106","article-title":"Structural basis for the inhibition of the essential <italic>Plasmodium falciparum<\/italic> M1 neutral aminopeptidase","volume":"106","author":"S McGowan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1074\/jbc.M609251200","article-title":"Characterization of the <italic>Plasmodium falciparum<\/italic> M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development","volume":"282","author":"CM Stack","year":"2007","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"30817","DOI":"10.1074\/jbc.M704938200","article-title":"The M18 aspartyl aminopeptidase of the human malaria parasite <italic>Plasmodium falciparum<\/italic>","volume":"282","author":"F Teuscher","year":"2007","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1073\/pnas.1105601108","article-title":"Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases","volume":"108","author":"MB Harbut","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27255","DOI":"10.1074\/jbc.M111.225318","article-title":"Distribution and biochemical properties of an M1-family aminopeptidase in <italic>Plasmodium falciparum<\/italic> indicate a role in vacuolar hemoglobin catabolism","volume":"286","author":"D Ragheb","year":"2011","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.1021\/jm301506h","article-title":"Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors","volume":"55","author":"R Deprez-Poulain","year":"2012","journal-title":"J Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/jm4005972","article-title":"Synthesis and Structure-Activity Relationships of Phosphonic Arginine Mimetics as Inhibitors of the M1 and M17 Aminopeptidases from <italic>Plasmodium falciparum<\/italic>","volume":"56","author":"Sivaraman K Kannan","year":"2013","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/AAC.06245-11","article-title":"The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria","volume":"56","author":"TS Skinner-Adams","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1021\/jm101227t","article-title":"Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase","volume":"54","author":"G Velmourougane","year":"2011","journal-title":"J Med Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jmb.2012.06.006","article-title":"X-ray crystal structure and specificity of the <italic>Plasmodium falciparum<\/italic> malaria aminopeptidase <italic>Pf<\/italic>M18AAP","volume":"422","author":"KK Sivaraman","year":"2012","journal-title":"J Mol Biol"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Sch\u00fcttelkopf AW, Aalten DMFv (2004) PRODRG\u2014a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr D60.","DOI":"10.1107\/S0907444904011679"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-60327-058-8_8","article-title":"Protein structure modeling with MODELLER","volume":"426","author":"N Eswar","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2105-13-S4-S2","article-title":"PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL","author":"E Bramucci","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"R Thomsen","year":"2006","journal-title":"J Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.biochi.2010.04.026","article-title":"Metallo-aminopeptidase inhibitors","volume":"92","author":"A Mucha","year":"2010","journal-title":"Biochimie"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"D343","DOI":"10.1093\/nar\/gkr987","article-title":"MEROPS: the database of proteolytic enzymes, their substrates and inhibitors","volume":"40","author":"ND Rawlings","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"1997","journal-title":"Adv Drug Del Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cmdc.200700290","article-title":"Zinc-binding groups modulate selective inhibition of MMPs","volume":"3","author":"A Agrawal","year":"2008","journal-title":"ChemMedChem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:50:58Z","timestamp":1589028658000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115859"}},"subtitle":[],"editor":[{"given":"Juan Carlos","family":"Pizarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115859","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}